Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch
Автор: Johns Hopkins Technology Ventures
Загружено: 2024-11-20
Просмотров: 338
First-in-class precision immunotherapies for autoimmune diseases. Selective depletion of autoreactive B cells with wide applicability across autoimmune and rheumatic diseases (e.g., antiphospholipid syndrome, lupus, rheumatoid arthritis). Normal immune cells are spared, eliminating risk of infection . Treatment of mild disease or even preclinical autoimmunity possible. Off-the-shelf, no need for conditioning, and maximally scalable
Innovator: Maximilian Konig, M.D.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: